Kersti Oselin1, Nicolas Girard2,3, Katrin Lepik4, Aidi Adamson-Raieste5, Tõnu Vanakesa6, Ingemar Almre6, Tiina Leismann4, Lara Chalabreysse2,7. 1. Department of Chemotherapy, North Estonia Medical Centre, Tallinn 13419, Estonia. 2. Université Lyon 1, Université de Lyon, Hospices Civils de Lyon, Lyon (Bron) 69677, France. 3. Institut Curie, Institut du Thorax Curie-Montsouris, Paris 75005, France. 4. Department of Pathology, North Estonia Medical Centre, Tallinn 13419, Estonia. 5. Department of Radiotherapy, North Estonia Medical Centre, Tallinn 13419, Estonia. 6. Department of Thoracic Surgery, North Estonia Medical Centre, Tallinn 13419, Estonia. 7. Centre Expert National Associé du Réseau RYTHMIC Tumeurs Thymiques et Cancer, Lyon, France.
Abstract
BACKGROUND: Thymic epithelial tumors are rare thoracic tumors for which pathological diagnosis is challenging due to the definition of multiple subtypes, tumor heterogeneity, and variations in interobserver reproducibility. In this study, we aimed at analyzing the quality of pathological reporting in line with the consistency between initial diagnosis and final diagnosis after expert review through a collaboration between the largest thoracic oncology center in Estonia, and one expert center in France. METHODS: Hospital electronic database and pathology databases from the Tallinn North Estonia Medical Centre were searched for thymic and mediastinal tumors from 2010 to 2017. Pathology specimens were referred to the Pathology Department of the Lyon University hospital. Overall, 55 tissue specimens from 49 patients were included. RESULTS: From pathology reports, tumor size, diagnosis, and invasion had been mentioned in ≥80% of cases, while resection status and staging were assessed in only 48% and 17% of cases, respectively. The initial diagnosis was consistent with that of the review in 60% of cases. Diagnostic concordance for thymoma subtypes was low (Cohen's kappa 0.34, 95% CI: 0.16-0.52). Overall, a major change in the management of 8 (16%) patients had to be made after pathological review: 3 patients had a normal thymus according to the reference centre, while thymoma B1 or B2 had been diagnosed locally; 5 additional patients had a final diagnosis of non-thymic tumor. CONCLUSIONS: Implementing structured pathology reports may help to decrease discrepancies in the diagnosis of thymic epithelial tumors. The development of expert networks is an opportunity to improve diagnosis and patient care, particularly in regard to rare cancers.
BACKGROUND: Thymic epithelial tumors are rare thoracic tumors for which pathological diagnosis is challenging due to the definition of multiple subtypes, tumor heterogeneity, and variations in interobserver reproducibility. In this study, we aimed at analyzing the quality of pathological reporting in line with the consistency between initial diagnosis and final diagnosis after expert review through a collaboration between the largest thoracic oncology center in Estonia, and one expert center in France. METHODS: Hospital electronic database and pathology databases from the Tallinn North Estonia Medical Centre were searched for thymic and mediastinal tumors from 2010 to 2017. Pathology specimens were referred to the Pathology Department of the Lyon University hospital. Overall, 55 tissue specimens from 49 patients were included. RESULTS: From pathology reports, tumor size, diagnosis, and invasion had been mentioned in ≥80% of cases, while resection status and staging were assessed in only 48% and 17% of cases, respectively. The initial diagnosis was consistent with that of the review in 60% of cases. Diagnostic concordance for thymoma subtypes was low (Cohen's kappa 0.34, 95% CI: 0.16-0.52). Overall, a major change in the management of 8 (16%) patients had to be made after pathological review: 3 patients had a normal thymus according to the reference centre, while thymoma B1 or B2 had been diagnosed locally; 5 additional patients had a final diagnosis of non-thymic tumor. CONCLUSIONS: Implementing structured pathology reports may help to decrease discrepancies in the diagnosis of thymic epithelial tumors. The development of expert networks is an opportunity to improve diagnosis and patient care, particularly in regard to rare cancers.
Authors: Faiz Y Bhora; David J Chen; Frank C Detterbeck; Hisao Asamura; Conrad Falkson; Pier Luigi Filosso; Giuseppe Giaccone; James Huang; Jhingook Kim; Kazuya Kondo; Marco Lucchi; Mirella Marino; Edith M Marom; Andrew G Nicholson; Meinoshin Okumura; Enrico Ruffini; Paul Van Schil Journal: J Thorac Oncol Date: 2014-09 Impact factor: 15.609
Authors: Frank C Detterbeck; Kelly Stratton; Dorothy Giroux; Hisao Asamura; John Crowley; Conrad Falkson; Pier Luigi Filosso; Aletta A Frazier; Giuseppe Giaccone; James Huang; Jhingook Kim; Kazuya Kondo; Marco Lucchi; Mirella Marino; Edith M Marom; Andrew G Nicholson; Meinoshin Okumura; Enrico Ruffini; Paul Van Schil Journal: J Thorac Oncol Date: 2014-09 Impact factor: 15.609
Authors: P A Zucali; L Di Tommaso; I Petrini; S Battista; H S Lee; M Merino; E Lorenzi; E Voulaz; F De Vincenzo; M Simonelli; M Roncalli; L Giordano; M Alloisio; A Santoro; G Giaccone Journal: Lung Cancer Date: 2012-12-29 Impact factor: 5.705
Authors: Ralf J Rieker; Josef Hoegel; Alicia Morresi-Hauf; Walter J Hofmann; Hendrik Blaeker; Roland Penzel; Herwart F Otto Journal: Int J Cancer Date: 2002-04-20 Impact factor: 7.396
Authors: Alexander Marx; Philipp Ströbel; Sunil S Badve; Lara Chalabreysse; John K C Chan; Gang Chen; Laurence de Leval; Frank Detterbeck; Nicolas Girard; Jim Huang; Michael O Kurrer; Libero Lauriola; Mirella Marino; Yoshihiro Matsuno; Thierry Jo Molina; Kiyoshi Mukai; Andrew G Nicholson; Daisuke Nonaka; Ralf Rieker; Juan Rosai; Enrico Ruffini; William D Travis Journal: J Thorac Oncol Date: 2014-05 Impact factor: 15.609
Authors: E T Verghese; M A den Bakker; A Campbell; A Hussein; A G Nicholson; A Rice; B Corrin; D Rassl; G Langman; H Monaghan; J Gosney; J Seet; K Kerr; S K Suvarna; M Burke; P Bishop; S Pomplun; S Willemsen; B Addis Journal: Histopathology Date: 2008-08 Impact factor: 5.087
Authors: Pier Luigi Filosso; Enrico Ruffini; Paolo Olivo Lausi; Marco Lucchi; Alberto Oliaro; Frank Detterbeck Journal: Lung Cancer Date: 2013-10-15 Impact factor: 5.705
Authors: Janina L Wolf; Francien van Nederveen; Hans Blaauwgeers; Alexander Marx; Andrew G Nicholson; Anja C Roden; Philipp Ströbel; Wim Timens; Annika Weissferdt; Jan von der Thüsen; Michael A den Bakker Journal: Histopathology Date: 2020-09-24 Impact factor: 5.087